Atovaquone
- Product NDC
- 72603-248
- 11-digit product format
- 726030248
- Labeler code
- 72603
- Product ID
- 72603-248_15e36ffa-2f19-ac0a-e063-6394a90afe22
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atovaquone
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- NorthStar RxLLC
- Application
- ANDA210692
- Marketing category
- ANDA
- Marketing start
- 2024-05-01
- Substance
- ATOVAQUONE
- Active strength
- 750 mg/5mL
- Pharmacologic classes
- Antimalarial [EPC], Antiprotozoal [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Atovaquone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ATOVAQUONE | 750 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | Y883P1Z2LT |
| Rxcui | 308429 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72603-248-01 | Atovaquone | 1 in 1 CARTON | SUSPENSION | 1 | | 1 |
| 72603-248-01 | Atovaquone | 210 mL in 1 BOTTLE | SUSPENSION | 210 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72603-248 | ATOVAQUONE (ATOVAQUONE) SUSPENSION [NORTHSTAR RXLLC] | 1 | Current NDC, 2 package rows | 20240501_fc7bdd97-f780-4eed-80e0-72e70267b21a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72603-248-01 | 72603024801 | 1 BOTTLE in 1 CARTON (72603-248-01) / 210 mL in 1 BOTTLE | 1 bottle | 2024-05-01 | No | No | Historical |